From:  Advancing our understanding of schizophrenia: insights from recent research, emerging therapies, and future directions

 Mapping core symptoms to implicated neural circuits and neurotransmitters.

Symptom categoryKey symptomsImplicated neural circuitsAssociated neurotransmitters/mechanisms
Positive symptomsHallucinations, delusionsMesolimbic pathway (e.g., nucleus accumbens, amygdala)↑ Dopamine (D2 receptor hyperactivity), NMDA receptor hypofunction
Negative symptomsAvolition, anhedonia, affective flatteningMesocortical pathway (e.g., prefrontal cortex)↓ Dopamine, ↓ NMDA receptor function, ↑ KYNA
Cognitive symptomsWorking memory deficits, executive dysfunctionPrefrontal cortex, hippocampus↓ Glutamate, ↑ KYNA, ↓ GABA, neuroinflammation
Affective symptomsAnxiety, depression, mood instabilityAmygdala, hypothalamus, limbic systemSerotonin, dopamine imbalance, and inflammatory cytokines
Motor symptomsCatatonia, abnormal movementsBasal ganglia, cerebellumDopamine dysregulation, oxidative stress, and synaptic dysfunction

↑: Increase, hyperactivity, or elevated function/levels of the specified neurotransmitter or mechanism; ↓: decrease, hypoactivity, or reduced function/levels of the specified neurotransmitter or mechanism. GABA: gamma-aminobutyric acid; KYNA: kynurenic acid; NMDA: N-methyl-D-aspartate.